DCM
Driehaus Capital Management Portfolio holdings
AUM
$12.5B
1-Year Return
79.21%
This Quarter Return
-1.9%
1 Year Return
+79.21%
3 Year Return
+526.69%
5 Year Return
+1,716.36%
10 Year Return
+17,720.68%
AUM
$10.4B
AUM Growth
-$1.74B
(-14%)
Cap. Flow
-$468M
Cap. Flow
% of AUM
-4.51%
Top 10 Holdings %
Top 10 Hldgs %
17.4%
Holding
476
New
95
Increased
124
Reduced
143
Closed
82
Top Buys
| 1 |
Guardant Health
GH
|
+$82.3M |
| 2 |
Sea Limited
SE
|
+$80.3M |
| 3 |
Elastic
ESTC
|
+$73.4M |
| 4 |
EXL Service
EXLS
|
+$57.7M |
| 5 |
BridgeBio Pharma
BBIO
|
+$51.9M |
Top Sells
| 1 |
Core Scientific
CORZ
|
+$144M |
| 2 |
Semtech
SMTC
|
+$126M |
| 3 |
Freshpet
FRPT
|
+$120M |
| 4 |
Modine Manufacturing
MOD
|
+$91.8M |
| 5 |
Credo Technology Group
CRDO
|
+$89.4M |
Sector Composition
| 1 | Healthcare | 24.7% |
| 2 | Technology | 18.5% |
| 3 | Industrials | 15.28% |
| 4 | Consumer Discretionary | 11.87% |
| 5 | Financials | 11.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
326
Baidu
BIDU
$37B
| $1.82M | 0.02% |
+19,761
| New | +$1.82M |
|
327
KLA
KLAC
$123B
| $1.79M | 0.02% |
+2,636
| New | +$1.79M |
|
|
RGLS
328
DELISTED
Regulus Therapeutics
RGLS
| $1.68M | 0.02% |
+958,345
| New | +$1.68M |
|
329
Apple
AAPL
$3.37T
| $1.65M | 0.02% |
7,415
-6,247
| -46% | -$1.39M |
|
330
Globant
GLOB
$2.52B
| $1.61M | 0.02% |
13,714
-251,666
| -95% | -$29.6M |
|
331
Telefônica Brasil
VIV
$19.7B
| $1.51M | 0.01% |
173,081
-199,060
| -53% | -$1.74M |
|
332
Exagen
XGN
$212M
| $1.5M | 0.01% |
418,505
| – | – |
|
|
MAZE
333
Maze Therapeutics, Inc. Common Stock
MAZE
$702M
| $1.45M | 0.01% |
+132,115
| New | +$1.45M |
|
334
Chunghwa Telecom
CHT
$34.5B
| $1.43M | 0.01% |
36,471
| – | – |
|
335
Pampa Energía
PAM
$3.38B
| $1.4M | 0.01% |
18,097
| – | – |
|
336
Eli Lilly
LLY
$676B
| $1.38M | 0.01% |
1,675
+708
| +73% | +$585K |
|
337
JPMorgan Chase
JPM
$826B
| $1.37M | 0.01% |
5,572
-70
| -1% | -$17.2K |
|
338
Alphabet (Google) Class A
GOOGL
$2.89T
| $1.37M | 0.01% |
8,836
+4,426
| +100% | +$684K |
|
339
Exxon Mobil
XOM
$480B
| $1.2M | 0.01% |
10,132
-2,595
| -20% | -$309K |
|
340
Protara Therapeutics
TARA
$120M
| $1.16M | 0.01% |
272,342
-244,810
| -47% | -$1.04M |
|
341
Philip Morris
PM
$257B
| $1.1M | 0.01% |
6,935
+2,669
| +63% | +$424K |
|
342
Linde
LIN
$222B
| $1.07M | 0.01% |
2,305
+279
| +14% | +$130K |
|
343
Walmart
WMT
$801B
| $1.02M | 0.01% |
11,566
-399
| -3% | -$35K |
|
344
Alcon
ALC
$38.5B
| $1M | 0.01% |
9,356
+3,133
| +50% | +$336K |
|
345
First Citizens BancShares
FCNCA
$25.2B
| $999K | 0.01% |
539
-122
| -18% | -$226K |
|
346
Skye Bioscience
SKYE
$128M
| $986K | 0.01% |
620,395
-30,363
| -5% | -$48.3K |
|
347
Motorola Solutions
MSI
$80.3B
| $968K | 0.01% |
2,211
| – | – |
|
348
Southern Company
SO
$101B
| $957K | 0.01% |
10,406
+6,262
| +151% | +$576K |
|
349
Broadcom
AVGO
$1.74T
| $948K | 0.01% |
5,662
-1,239
| -18% | -$207K |
|
350
Truist Financial
TFC
$58.2B
| $894K | 0.01% |
21,719
| – | – |
|